Chronic Co-Morbid Conditions in HIV+ U.S. Adults on Highly-Effective Anti-Retroviral Therapy (R01)
Published Date
Agency
CFDA
93.361
Contact Information
Kelly Oster, 301-594-2177; Osterk@mail.nih.gov
Deadline
Department
Eligiblity
State, local and tribal governments, school districts, institutions of higher education, public housing authorities, Indian housing authorities, Native American tribal organizations, nonprofit organizations and for profit organizations, including small businesses
Guide Page Reference
None
More Information
Program Area
Programe Purpose
To support mechanistic projects or interventions designed to understand or intervene in chronic co-morbid conditions common to HIV+ adults living in the U.S. who are treated with anti-retroviral therapy
